129 related articles for article (PubMed ID: 30254334)
1. GA-Hecate antiviral properties on HCV whole cycle represent a new antiviral class and open the door for the development of broad spectrum antivirals.
Batista MN; Sanches PRDS; Carneiro BM; Braga ACS; Campos GRF; Cilli EM; Rahal P
Sci Rep; 2018 Sep; 8(1):14329. PubMed ID: 30254334
[TBL] [Abstract][Full Text] [Related]
2. Antiviral Evaluation of New Synthetic Bioconjugates Based on GA-Hecate: A New Class of Antivirals Targeting Different Steps of Zika Virus Replication.
da Silva Sanches PR; Velazquez RS; Batista MN; Carneiro BM; Bittar C; De Lorenzo G; Rahal P; Patel AH; Cilli EM
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446546
[TBL] [Abstract][Full Text] [Related]
3. Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry.
Hsu WC; Chang SP; Lin LC; Li CL; Richardson CD; Lin CC; Lin LT
Antiviral Res; 2015 Jun; 118():139-47. PubMed ID: 25865056
[TBL] [Abstract][Full Text] [Related]
4. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
[TBL] [Abstract][Full Text] [Related]
5. A conjugate of the lytic peptide Hecate and gallic acid: structure, activity against cervical cancer, and toxicity.
Sanches PR; Carneiro BM; Batista MN; Braga AC; Lorenzón EN; Rahal P; Cilli EM
Amino Acids; 2015 Jul; 47(7):1433-43. PubMed ID: 25868656
[TBL] [Abstract][Full Text] [Related]
6. Anti-hepatitis C virus activity and synergistic effect of Nymphaea alba extracts and bioactive constituents in liver infected cells.
Rehman S; Ashfaq UA; Ijaz B; Riazuddin S
Microb Pathog; 2018 Aug; 121():198-209. PubMed ID: 29775725
[TBL] [Abstract][Full Text] [Related]
7. Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry.
Behrendt P; Perin P; Menzel N; Banda D; Pfaender S; Alves MP; Thiel V; Meuleman P; Colpitts CC; Schang LM; Vondran FWR; Anggakusuma ; Manns MP; Steinmann E; Pietschmann T
Antiviral Res; 2017 Nov; 147():19-28. PubMed ID: 28923507
[TBL] [Abstract][Full Text] [Related]
8. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel anti-hepatitis C virus agents by a quantitative high throughput screen in a cell-based infection assay.
Hu Z; Hu X; He S; Yim HJ; Xiao J; Swaroop M; Tanega C; Zhang YQ; Yi G; Kao CC; Marugan J; Ferrer M; Zheng W; Southall N; Liang TJ
Antiviral Res; 2015 Dec; 124():20-9. PubMed ID: 26515788
[TBL] [Abstract][Full Text] [Related]
10. Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus.
Vausselin T; Séron K; Lavie M; Mesalam AA; Lemasson M; Belouzard S; Fénéant L; Danneels A; Rouillé Y; Cocquerel L; Foquet L; Rosenberg AR; Wychowski C; Meuleman P; Melnyk P; Dubuisson J
J Virol; 2016 Oct; 90(19):8422-34. PubMed ID: 27412600
[TBL] [Abstract][Full Text] [Related]
11. The kinase-inhibitor sorafenib inhibits multiple steps of the Hepatitis C Virus infectious cycle in vitro.
Descamps V; Helle F; Louandre C; Martin E; Brochot E; Izquierdo L; Fournier C; Hoffmann TW; Castelain S; Duverlie G; Galmiche A; François C
Antiviral Res; 2015 Jun; 118():93-102. PubMed ID: 25823619
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus resistance to protease inhibitors.
Halfon P; Locarnini S
J Hepatol; 2011 Jul; 55(1):192-206. PubMed ID: 21284949
[TBL] [Abstract][Full Text] [Related]
13. [Antiviral agents for analyzing virus life cycle: chemical genetics for virology].
Watashi K
Yakugaku Zasshi; 2013; 133(11):1169-75. PubMed ID: 24189558
[TBL] [Abstract][Full Text] [Related]
14. Development of an Aryloxazole Class of Hepatitis C Virus Inhibitors Targeting the Entry Stage of the Viral Replication Cycle.
He S; Li K; Lin B; Hu Z; Xiao J; Hu X; Wang AQ; Xu X; Ferrer M; Southall N; Zheng W; Aubé J; Schoenen FJ; Marugan JJ; Liang TJ; Frankowski KJ
J Med Chem; 2017 Jul; 60(14):6364-6383. PubMed ID: 28636348
[TBL] [Abstract][Full Text] [Related]
15. A novel small-molecule inhibitor of hepatitis C virus replication acts by suppressing signal transducer and activator of transcription 3.
Niu Y; Si Y; Li Y; Chi X; Li X; Liu X; Li D; Cheng M; Fan J; Si S; Yang W
J Antimicrob Chemother; 2015 Jul; 70(7):2013-23. PubMed ID: 25858355
[TBL] [Abstract][Full Text] [Related]
16. A novel class of geldanamycin derivatives as HCV replication inhibitors targeting on Hsp90: synthesis, structure-activity relationships and anti-HCV activity in GS4.3 replicon cells.
Shan GZ; Peng ZG; Li YH; Li D; Li YP; Meng S; Gao LY; Jiang JD; Li ZR
J Antibiot (Tokyo); 2011 Feb; 64(2):177-82. PubMed ID: 21179047
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus complete life cycle screen for identification of small molecules with pro- or antiviral activity.
Gentzsch J; Hinkelmann B; Kaderali L; Irschik H; Jansen R; Sasse F; Frank R; Pietschmann T
Antiviral Res; 2011 Feb; 89(2):136-48. PubMed ID: 21167208
[TBL] [Abstract][Full Text] [Related]
18. Benzothiazepinecarboxamides: Novel hepatitis C virus inhibitors that interfere with viral entry and the generation of infectious virions.
Kim HY; Kong S; Oh S; Yang J; Jo E; Ko Y; Kim SH; Hwang JY; Song R; Windisch MP
Antiviral Res; 2016 May; 129():39-46. PubMed ID: 26850830
[TBL] [Abstract][Full Text] [Related]
19. A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle.
Chockalingam K; Simeon RL; Rice CM; Chen Z
Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3764-9. PubMed ID: 20142494
[TBL] [Abstract][Full Text] [Related]
20. An amphipathic alpha-helical synthetic peptide analogue of melittin inhibits herpes simplex virus-1 (HSV-1)-induced cell fusion and virus spread.
Baghian A; Jaynes J; Enright F; Kousoulas KG
Peptides; 1997; 18(2):177-83. PubMed ID: 9149288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
